Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14449088 | 1.00 | TP53 (0.43) | TP53MAPK1RAB9AKDM4ETSHR | |
| SCHEMBL20375119 | 0.86 | TP53 (0.48) | TP53MAPK1RAB9AKDM4ETSHR | |
| SCHEMBL18560859 | 0.86 | TP53 (0.48) | TP53MAPK1RAB9AKDM4ETSHR | |
| SCHEMBL29419414 | 0.86 | TP53 (0.48) | TP53MAPK1RAB9AKDM4ETSHR | |
| SCHEMBL24834544 | 0.81 | FFAR4 (0.51) | MAPK1KDM4ETSHRFFAR4TDP1 | |
| SCHEMBL13005234 | 0.81 | FFAR4 (0.51) | MAPK1KDM4ETSHRFFAR4TDP1 | |
| SCHEMBL4403001 | 0.80 | KDM4E (0.50) | MAPK1KDM4ETSHRFFAR4TDP1 | |
| SCHEMBL4403004 | 0.78 | HTR1B (0.43) | KDM4ETSHRTDP1MEN1KMT2A | |
| SCHEMBL201988 | 0.76 | CHRNB2 (0.56) | KDM4EFFAR4TDP1ALDH1A1 | |
| SCHEMBL18587062 | 0.76 | KDM4E (0.44) | KDM4ETSHRHTR7TDP1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120077076-A | Composition and method for producing the same | 默克专利有限公司 | 2025-05-30 | — | — | CN | claimed |
| US-11667731-B2 | Stabilized UV active organopalladium compounds as vinyl addition catalysts | PROMERUS, LLC (US) | 2023-06-06 | — | — | US | claimed |
| US-20230038665-A1 | STABILIZED UV ACTIVE ORGANOPALLADIUM COMPOUNDS AS VINYL ADDITON CATALYSTS | PROMERUS, LLC (US) | 2023-02-09 | — | — | US | claimed |
| CN-120077076-A | Composition and method for producing the same | 默克专利有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-12037431-B2 | Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof | PROMERUS, LLC (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037431-B2 | Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof | PROMERUS, LLC (US) | 2024-07-16 | — | — | US | disclosed |
| CN-118317992-A | Dual UV blocker comprising a shelf-life stable photoactive bulk polymerized polycycloolefin composition as an optical material | 普罗米鲁斯有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024083874-A1 | COMPOSITION | MERCK PATENT GMBH (DE) | 2024-04-25 | — | — | WO | disclosed |
| US-11897991-B2 | UV active derivatives of Pd(AcAc)2 catalyzed polycycloolefin compositions as optical materials | PROMERUS, LLC (US) | 2024-02-13 | — | — | US | disclosed |
| EP-4288479-A1 | LONG SHELF LIFE STABLE PHOTOACTIVE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS OPTICAL MATERIALS | Promerus, LLC (US) | 2023-12-13 | — | — | EP | disclosed |
| US-11795285-B2 | Dual UV blockers containing stable photoactive mass polymerizable polycycloolefin compositions as optical materials | PROMERUS, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-8178604-B2 | Solid materials obtainable by ring-opening metathesis polymerization | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| EP-1815838-B1 | Solid materials obtainable by the ring-opening methathesis polymerization | 3M INNOVATIVE PROPERTIES CO (US) | 2010-09-08 | — | — | EP | disclosed |
| US-20100036015-A1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | 3M INNOVATIVE PROPERTIES COMPANY | 2010-02-11 | — | — | US | disclosed |
| US-20100036015-A1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | 3M INNOVATIVE PROPERTIES COMPANY | 2010-02-11 | — | — | US | disclosed |
| US-20090088494-A1 | SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION | 3M INNOVATIVE PROPERTIES COMPANY | 2009-04-02 | — | — | US | disclosed |
| US-20090088494-A1 | SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION | 3M INNOVATIVE PROPERTIES COMPANY | 2009-04-02 | — | — | US | disclosed |
| EP-1942125-A1 | Compositions curable by ring opening metathesis polymerarization at low temperatures and their application in the dental field | 3M Innovative Properties Company (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2008077001-A1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-06-26 | — | — | WO | disclosed |
| WO-2007089801-A1 | SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100036015-A1 | COMPOSITIONS CURABLE BY RING OPENING METATHESIS POLYMERIZATION AT LOW TEMPERATURES AND THEIR APPLICATION IN THE DENTAL FIELD | DNMT3B, HMBS, MMAB | TP53 4156/4885MAPK1 4405/4885RAB9A 1469/4885 |
| US-12037431-B2 | Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof | RRP15, PPOX, NONO | TP53 2803/4885MAPK1 2955/4885RAB9A 2324/4885 |
| US-20090088494-A1 | SOLID MATERIALS OBTAINABLE BY RING-OPENING METATHESIS POLYMERIZATION | MMAB, DNMT3B, RHEB | TP53 3149/4885MAPK1 4200/4885RAB9A 926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.